Study finds newly approved breast cancer drug defeats the Ras genes notorious for causing many types of cancer
Virginia Commonwealth University News | Oct 16, 2017
Handheld device monitors breast cancer lesions
Carnegie Mellon University News | Oct 15, 2017
Discovery of a new fusion gene class may affect the development of cancer
Lund University News | Oct 15, 2017
P53 "master switch" remains top target in gene signaling network controlling cancer suppression
University of Colorado Health News | Oct 15, 2017
A new genetic marker accounts for up to 1.4% of cases of hereditary colon cancer
IDIBELL-Bellvitge Biomedical Research Institute News | Oct 14, 2017
Better understanding of bladder cancer subtypes might lead to improved treatments
Baylor College of Medicine News | Oct 14, 2017
Therapeutic targeting of p53
European Society for Medical Oncology News | Oct 14, 2017
SUNY Downstateâs incubator program launches company revolutionizing bone marrow transplant process
SUNY Downstate Medical Center News | Oct 14, 2017
Trastuzumab treatment for HER-2-expressing tumors need not delay breast reconstruction following mastectomy
American College of Surgeons News | Oct 14, 2017
New mutations in iPS cells are mainly concentrated in non-transcriptional regions
RIKEN News | Oct 14, 2017